The effect of leukotriene antagonists, lipoxygenase inhibitors and selected standards on leukotriene-mediated allergic bronchospasm in guinea pigs

Agents and Actions
W KreutnerC Rizzo


Leukotrienes (LT) C4, D4, and E4 are major contributors to the pathobiology of human bronchial asthma. Therefore, it is likely that compounds that antagonize the action or inhibit the formation of LTs will be useful therapeutic agents. We have studied the effects of LT antagonists, 5-lipoxygenase inhibitors and selected standards in a model of LT-mediated allergic bronchospasm in guinea pigs. Sensitized animals were pretreated with mepyramine, indomethacin and propranolol to eliminate the influence of histamine, prostaglandins, thromboxanes and circulating catecholamines. In these animals, inhalation of antigen resulted in a bronchospasm consistent with a LT-mediated response that was slow in onset, of long duration and was inhibited by the selective LTD4, antagonists FPL-55712, LY-171,883 and ICI-198,615. ICI-198,615 was approximately 50-times more potent than FPL-55712 by the intravenous and intratracheal routes. However, of thirteen compounds known to inhibit 5-lipoxygenase and LT biosynthesis in vitro only phenidone, piriprost and AA-861 were active in this in vivo model. The allergic bronchospasm was inhibited by bronchodilators (e.g. PGE2, aminophylline and forskolin) and by some mast cell stabilizers, but was otherwise i...Continue Reading


Jan 1, 1978·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·N Svedmyr, B G Simonsson
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R C MurphyB Samuelsson
Nov 1, 1979·The Journal of Pharmacy and Pharmacology·J R Walker, W Dawson
Jan 1, 1977·International Archives of Allergy and Applied Immunology·J El-Azab, P B Stewart
Dec 1, 1978·The Journal of Allergy and Clinical Immunology·R PattersonK E Harris
Jan 1, 1978·Clinical Immunology and Immunopathology·I BroderE N Milne
Jun 1, 1977·Acta Physiologica Scandinavica·K Strandberg, P Hedqvist
Oct 1, 1977·Agents and Actions·J AugsteinP Sheard
Jan 1, 1976·Life Sciences·J A Zivin, J J Bartko
Apr 23, 1985·European Journal of Pharmacology·W KreutnerS Tozzi
Aug 1, 1985·The Journal of Allergy and Clinical Immunology·M Kaliner
Mar 15, 1986·Biochemical Pharmacology·J R BeetensF De Clerck
Jun 1, 1987·British Journal of Clinical Pharmacology·R W FullerE Philipp
Jun 1, 1986·Agents and Actions·J H MusserA J Lewis
Jun 1, 1987·The Journal of Allergy and Clinical Immunology·L Hendeles, E Harman
Oct 17, 1973·Nature: New Biology·J AugsteinM L Tattersall
Jan 1, 1969·Advances in Immunology·R P Orange, K F Austen
Jun 1, 1967·British Journal of Pharmacology and Chemotherapy·H O Collier, G W James
Sep 28, 1973·Nature·J G Shire
Dec 1, 1967·European Journal of Pharmacology·M W McCullochM J Rand
Feb 12, 1980·Biochemical and Biophysical Research Communications·S HammarströmE J Corey
Dec 4, 1980·Nature·S E DahlénB Samuelsson
Jul 4, 1981·Lancet·M C HolroydeE V Elliott
Feb 1, 1982·The Journal of Clinical Investigation·W F Stenson, E Lobos
Jan 1, 1982·International Archives of Allergy and Applied Immunology·J R BootW Dawson
Oct 2, 1980·The New England Journal of Medicine·E J Goetzl
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·S E DahlénB Dahlén
Jan 17, 1984·Biochimica Et Biophysica Acta·Y KoshiharaT Tatsuno
Jan 1, 1983·International Archives of Allergy and Applied Immunology·H G JohnsonH W Smith
Apr 25, 1983·Life Sciences·Z TerashitaK Nishikawa
Aug 29, 1983·Biochimica Et Biophysica Acta·T NeichiS Murota
Jun 1, 1984·British Journal of Pharmacology·R CarrierC A Stone
Nov 1, 1980·Acta Physiologica Scandinavica·P HedqvistB Samuelsson
Dec 1, 1981·Agents and Actions·M C HolroydeE V Elliott
Apr 9, 1982·Science·J W WeissK F Austen
Jul 1, 1981·Agents and Actions·D M RitchieM E Rosenthale


Sep 1, 1997·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·G ThomasD P De Souza
Apr 1, 1993·The Journal of Allergy and Clinical Immunology·C D WegnerC C Clarke

Related Concepts

Eicosatetraenoic Acids
Bronchial Spasm
Calcium Channel Blockers
Cavia porcellus
Antispasmodic Effect
Respiratory Hypersensitivity
Arachidonic Acid, Zinc Salt, (all-Z)-Isomer

Related Feeds


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.